Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-03 Sale | 2022-10-05 5:00 pm | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 50,000 | $33.65 | $1,682,622 | 778,828 (Indirect Direct) | View |
| 2022-08-10 Sale | 2022-08-11 5:00 pm | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 50,000 | $29.9 | $1,495,000 | 807,258 (Indirect Direct) | View |
| 2022-07-19 Sale | 2022-07-21 5:00 pm | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 50,000 | $29.9 | $1,495,000 | 857,258 (Indirect Direct) | View |
| 2022-01-04 Sale | 2022-01-06 4:36 pm | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 1,870 | $39.9 | $74,613 | 835,955 (Indirect Direct) | View |
| 2021-12-27 Sale | 2021-12-29 4:38 pm | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 48,693 | $40.16 | $1,955,534 | 1,113,813 (Indirect Direct) | View |
| 2021-12-22 Sale | 2021-12-27 6:08 pm | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 114,000 | $39.3 | $4,480,604 | 1,261,506 (Indirect Direct) | View |
| 2021-06-21 Purchase | 2021-06-21 6:20 pm | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 2,500 | $19 | $47,500 | 622,528 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Option Award | 2024-02-16 4:30 pm | N/A 2034-02-13 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 658,000 | $0 | 658,000 (Direct) | View |
| 2023-05-31 Option Award | 2023-06-01 6:39 pm | N/A 2033-05-30 | Relay Therapeutics Inc. | RLAY | Kathiresan Sekar Director | 66,055 | $0 | 66,055 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 5:00 pm | N/A 2033-02-13 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 550,200 | $0 | 550,200 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 5:00 pm | N/A 2029-04-14 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 50,000 | $0 | 778,828 (Direct) | View |
| 2022-10-03 Exercise | 2022-10-05 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 50,000 | $1.39 | 778,828 (Direct) | View |
| 2022-08-10 Exercise | 2022-08-11 5:00 pm | N/A 2029-04-14 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 50,000 | $0 | 807,258 (Direct) | View |
| 2022-08-10 Exercise | 2022-08-11 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 50,000 | $1.39 | 807,258 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 6:57 pm | N/A 2032-07-24 | Relay Therapeutics Inc. | RLAY | Kathiresan Sekar Director | 71,881 | $0 | 71,881 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 5:00 pm | N/A 2029-04-14 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 50,000 | $0 | 857,258 (Direct) | View |
| 2022-07-19 Exercise | 2022-07-21 5:00 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 50,000 | $1.39 | 857,258 (Direct) | View |
| 2022-07-12 Gift | 2022-07-15 5:00 pm | N/A 2031-02-11 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 760,000 | $0 | 1,817,129 (Direct) | View |
| 2022-03-18 Exercise | 2022-03-22 07:41 am | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 69,674 | $2.87 | 1,244,827 (Direct) | View |
| 2022-03-18 Exercise | 2022-03-22 07:41 am | N/A 2030-09-15 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 69,674 | $0 | 1,244,827 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 08:58 am | N/A 2032-02-10 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 332,000 | $0 | 332,000 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-06 4:36 pm | N/A 2029-04-14 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 1,870 | $0 | 835,955 (Direct) | View |
| 2022-01-04 Exercise | 2022-01-06 4:36 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 1,870 | $1.39 | 835,955 (Direct) | View |
| 2021-12-27 Exercise | 2021-12-29 4:38 pm | N/A 2029-04-14 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 48,693 | $0 | 1,113,813 (Direct) | View |
| 2021-12-27 Exercise | 2021-12-29 4:38 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 48,693 | $1.39 | 1,113,813 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-27 6:08 pm | N/A 2029-04-14 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 114,000 | $0 | 1,261,506 (Direct) | View |
| 2021-12-22 Exercise | 2021-12-27 6:08 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 114,000 | $1.39 | 1,261,506 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 6:20 pm | N/A 2031-06-16 | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer | 53,998 | $0 | 622,528 (Direct) | View |
Ownership | 2021-06-16 7:42 pm | N/A N/A | Verve Therapeutics Inc. | VERV | Kathiresan Sekar Chief Executive Officer 10% Owner | 0 | $0 | 2,293,983 (Direct) | View |